ArticleJournal of clinical medicine2020

Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study.

Celestino Sardu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.